During studies on the ATPase activity of purified human liver alkaline phosphatase we noted that this activity was inhibited at ATP concentrations greater than 0.5mM. Several reports have documented a similar effect on (Na++K+)-stimulated ATPase Hudgins & Bond, 1977; Beauge & Glynn, 1978) , when the ATP used was from an extract of horse muscle. No inhibitor has been found in ATP from yeast. Cantley et al. (1977) and Quist & Hokin (1978) have now identified the inhibitor as orthovanadate (VO43-). This compound has previously been shown to be an inhibitor of alkaline phosphatase from Escherichia coli (Lopez et al., 1976) and acid phosphatase from human liver or wheat germ (Van Etten et al., 1974) .
The present report demonstrates that human liver alkaline phosphatase from several human tissues is inhibited by physiological concentrations of orthovanadate. In addition it is shown that orthovanadate and phosphate bind to human liver alkaline phosphatase in a mutually exclusive fashion.
Materials and Methods
Sodium orthovanadate (Na3VO4) was obtained from Fisher Scientific Co., Fair Lawn, NJ, U.S.A.; the vanadate concentration was determined indirectly by analysis for sodium by flame photometry. The following were from Sigma Chemical Co., St. Louis, MO, U.S.A.: p-nitrophenyl phosphate, ATP (horse muscle, no. 6144), vanadium-free ATP (horse muscle, no. 5394) and L-adrenaline. Alkaline phosphatase (EC 3.1.3.1) was purified from human liver, kidney or small-intestinal mucosa by a modification of the procedure previously described (Trepanier et al., 1976; Seargeant & Stinson, 1979a) . The enzyme preparations appeared to be free of contaminating protein, as judged by polyacrylamide-gel electrophoresis with and without sodium dodecyl sulphate. The specific activity of the enzyme from liver was 1300pmol/min per mg. The procedures for polyacrylamide-gel electrophoresis with and without sodium dodecyl sulphate and staining for Vol. 181 enzyme activity or protein were as described previously (Trepanier et al., 1976) .
Enzyme activity with p-nitrophenyl phosphate as substrate was measured as described (Trepanier et al., 1976) in a buffer mixture that contained 25mM-2-methyl-2-aminopropan-1-ol, 25mM-Tes (2-{[2-hydroxy-,1 -bis(hydroxymethyl)ethyl]amino}ethane-sulphonic acid), 25mM-Tris and 1.5mM-MgCI2 (pH adjusted with HCI) at substrate concentrations that ranged from 5 to 100pUM (pH7.4) or 25 to 1000pUM (pH 9.0). When the influence of L-adrenaline on vanadate inhibition was studied, activity was monitored by the release of phosphate (Anner & Moosmayer, 1975) .
ATPase activity was measured at pH 8.0 as described above by the amount of phosphate released (LeBel etal., 1978) . Since Mg2+ ions inhibited ATPase activity, the MgCl2 concentration was kept at 5pgM.
Inhibition constants were determined from doublereciprocal plots (Lineweaver & Burk, 1934) or Dixon (1953) plots.
Results and Discussion
The results for the hydrolysis of ATP by human liver alkaline phosphatase when commercial ATP from horse muscle that contains 5-40p.p.m. of vanadium (molar ratio up to 1:2000) was used are shown in Fig. 1 . The observed inhibitory effect was nearly absent when vanadium-free ATP was used, but could be partially restored upon addition of Na3VO4 (Fig. 1) . Although the vanadium concentration was not determined in the ATP used for these experiments, the concentration was presumably in the range stated by the supplier (molar ratio up to 1:2000). Since less inhibition was observed when vanadate was added to vanadium-free ATP in a molar ratio of 1:1000, the inhibition cannot be attributed solely to the presence of vanadate. Quist & Hokin (1978) [ATPI (mM) Fig. 1 . Effect of increasing substrate concentration on the ATPase activity of alkaline phosphatase from human liver Enzyme activity was measured at pH 9.0 at an enzyme concentration of 40 ng/ml as described in the Materials and Methods section. *, ATP extracted from horse muscle; o, ATP from horse muscle that had been treated to remove vanadium; A, vanadiumfree ATP to which orthovanadate had been added in a molar ratio of 1:1000.
phosphatases purified from human liver, intestine and kidney (Fig. 2 , Table 1 ). The inhibition constants at pH7.4 and 9.0 are approx. 100-fold lower than the corresponding values for phosphate. This is in contrast with the enzyme from E. coli, in which the inhibitor constants are of similar magnitude. The series of parallel lines obtained from the YonetaniTheorell (1964) plot shown in Fig. 3 for the human liver enzyme suggests that the two inhibitors, phosphate and orthovanadate, bind in a mutually exclusive fashion. Similar findings have been reported for E. coli alkaline phosphatase (Lopez et al., 1976 ).
Yonetani-Theorell plots were not done with the enzymes from kidney or intestine, but it is probable that results similar to the above would be obtained.
The Ki values reported in Table 1 are ofthe same order as reported by Cantley et al. (1977) for the (Na++K+)-stimulated ATPase from striated muscle. and dynein ATPase (Kobayashi et al., 1978; Gibbons et al., 1978) . Adrenaline is known to form complexes with vanadate (Kustin et al., 1974) , so it is probable that the reversal of inhibition is due to complexing of vanadate.
With the exception of alkaline phosphatase it appears that (Na+ + K+)-stimulated ATPase and dynein ATPase are the only ATPases that are inhibited by vanadate ions; Ca2+-stimulated ATPase from sarcoplasmic reticulum, actomyosin ATPase and the F1-ATPase from mitochondria are all relatively insensitive to the metal Quist & Hokin, 1978) . Intestinal alkaline phosphatase has been suggested to be a Ca2+-stimulated ATPase (Haussler et al., 1970; Russell et al., 1972) , but, since intestinal alkaline phosphatase is inhibited by vanadate and Ca2+-stimulated ATPase is apparently not, it appears that the two enzyme activities are distinct. It is possible, however, that the intestinal enzyme acquired sensitivity to vanadate as a result of the process of purification.
Vanadate ions do not inhibit the ATPases in a strictly competitive manner Kobayashi et al., 1978) as observed for alkaline phosphatase (Fig. 2) . Cantley et al. (1978) have found two vanadate-binding sites on the (Na+ + K+)-stimulated ATPase from dog kidney and suggest that the ion may be a physiological regulator of the enzyme. Tissue concentrations of the metal are in the near-micromolar range, with concentrations of 20-30,ig/kg dry wt. in adult human liver, spleen, pancreas and prostate gland (Underwood, 1962) .
Since the Ki values reported herein are less than I AM, it appears that the phosphohydrolytic activity of alkaline phosphatase in ViLo could also be influenced by vanadate ions.
The more potent inhibition of alkaline phosphatase by orthovanadate than by phosphate suggests that the former compound through hydration or chelation can resemble a transition-state analogue of phosphate in the mechanism that involves a phosphoryl-enzyme intermediate. Lopez et al. (1976) point out that one of the transition states may be a trigonal bypyramidal species, and vanadate can resemble this type of structure (Lopez et al., 1976; Van Etten et al., 1974) .
